Skip to content

Prof Eli Silber

Professor of Clinical Neurology

Year Qualified
1989
Qualifications
MBBCh, FCP(Neuro)SA, MD(Lond) FRCP
Specialty
Neurology

Special Interests

  • Multiple Sclerosis Neuroimmunology

Biography

Prof Eli Silber studied medicine at the University of the Witwatersrand and completed his neurology training in Soweto, South Africa. He came to the UK in 1997. He joined the Department of Neuroimmunology at Guy’s Hospital where his MD thesis investigated the causes of disability in multiple sclerosis (MS) by developing an antibody assay as a biomarker of axonal damage in MS. Since 2000, he has been Consultant Neurologist at the King’s Regional Neurosciences Centre and at Queen Elizabeth Hospital, London.

Eli set up the Regional MS Service based at King’s College Hospital as well as a satellite service at Queen Elizabeth Hospital. This service is involved in the diagnosis and management of people with MS and other immune disorders of the nervous system, including provision of specialist opinions in complex cases and assessment for disease modifying therapies.

Eli has an interest in neurological infections and supports a monthly neurology HIV clinic and multi-disciplinary team (MDT) meeting. He enjoys teaching and has been nominated for teaching awards by his medical students. He co-supervises masters and doctoral students.

Related services

Research

Prof Silber’s clinical and research interests include extending care for people with MS. This includes a model service for mental health problems (shortlisted Guardian Public Service Awards 2007), palliative care for people with advanced MS and MS in ethnic minorities. He continues to conduct research and publish on aspects of MS.

Eli established one of the most successful clinical trial groups at King’s College Hospital. He has been lead investigator in many of the trials of novel therapeutic agents for people with MS. He collaborates with colleagues in the advancement of therapies for patients with aggressive disease, including haemopoietic stem cell transplantation.